Nitroimidazoles for imaging hypoxic myocardium

This publication has 31 references indexed in Scilit:

• Myocardial Kinetics of a Putative Hypoxic Tissue Marker, ^99m Tc-Labeled Nitroimidazole (BMS-181321), After Regional Ischemia and Reperfusion
  Circulation, 1995
• Nitroimidazoles and imaging hypoxia
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease
  New England Journal of Medicine, 1995
• TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction
  Journal of Medicinal Chemistry, 1994
• Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging
  Journal of Medicinal Chemistry, 1991
• Xanthine oxidoreductase activity in perfused hearts of various species, including humans.
  Circulation Research, 1990
• The metabolic activation of nitroheterocyclic therapeutic agents
  Drug Metabolism Reviews, 1988
• Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissue
  Applied Radiation and Isotopes, 1986
• The labelling of EMT-6 tumours in BALB/C mice with¹⁴C-misonidazole
  The British Journal of Radiology, 1983
• Structure-activity Relationships in the Development of Hypoxic Cell Radiosensitizers
  International Journal of Radiation Biology, 1979